The effects of in vitro hemodilution with 6% hydroxyethyl starch (HES) (130/0.4) solution on thrombelastograph analysis in patients undergoing liver transplantation

Si Ra Bang, Yoon Hee Kim, Gaab Soo Kim

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Abstract

Introduction: The aim of this study was to determine the effects of in vitro hemodilution with 6% HES (130/0.4) solution on thrombelastograph® (TEG) parameters in whole blood samples from patients with end-stage liver disease (ESLD). Methods: Enrollment consisted of 95 patients with ESLD undergoing liver transplantation. Blood was diluted by 11%, 22%, and 33% with 6% HES (130/0.4) solution. Normal saline was used as a control diluent. Results: When blood was diluted by 33% with normal saline, only the reaction time (r) was increased (p<0.0001) compared to the baseline value. When blood was diluted with 6% HES (130/0.4), 11% dilution decreased maximum amplitude (MA) (p=0.003) compared to baseline. At 33% dilution, the r (p<0.0001, vs. baseline) and K (p<0.0001, vs. baseline; p<0.0001, vs. normal saline) increased, and the MA, alpha angle, and coagulation index (p<0.0001, vs. baseline; p<0.0001, vs. normal saline) decreased. Conclusion: Hemodilution with 6% HES (130/0.4) solution results in TEG abnormalities even with 11% hemodilution, in whole blood samples of patients with ESLD undergoing liver transplantation.

Original languageEnglish
Pages (from-to)450-456
Number of pages7
JournalClinical Transplantation
Volume25
Issue number3
DOIs
StatePublished - May 2011

Keywords

  • 6% HES 130/0.4 (hydroxyethyl starch) solution
  • End-stage liver disease
  • Hemodilution
  • Liver transplantation
  • Thrombelastograph

Fingerprint

Dive into the research topics of 'The effects of in vitro hemodilution with 6% hydroxyethyl starch (HES) (130/0.4) solution on thrombelastograph analysis in patients undergoing liver transplantation'. Together they form a unique fingerprint.

Cite this